EGFR and non-small cell lung carcinoma: More recently, one of the most often targeted cell-surface entities has been EGFR (epidermal growth factor receptor, overexpressed in a variety of solid tumors such as non-small cell lung cancer, head and neck carcinoma, ovarian, kidney, and pancreatic cancer).